Follow Us:

Steering Committee

Workshop Co-Chairs

Bo Huang, Pfizer Inc.
Gene Pennello, FDA/CDRH

Steering Committee

FDA

Thomas Birkner, CDER
Stuart Chirtel, CFSAN
Christopher Ellison, CTP
Xin Fang, CVM
Cherry Gupta, CVM
Lin Huo, CBER
Jennifer Kirk, CBER
Chia-Wen (Kiki) Ko, CDRH
Semhar Ogbagaber, CDER
Norberto Pantoja-Galicia, CDRH
Paul Rogers, NCTR
Claire Ruberman, CVM
Haiwen Shi, CVM
Hengrui Sun, CDER
James Travis, CDER
Sherman Xia, CDER
Xiaoqin Xiong, CDRH
Mengdie Yuan, CDER
Wei (Vivian) Zhuang, NCTR

Industry

Paul Bycott, Pfizer Inc.
Joe Cappelleri, Pfizer Inc.
Cong Chen, Merck & Co., Inc.
Jie Chen, Overland
Freda Cooner, Amgen
Qiqi Deng, Boehringer-Ingelheim
Frank Fan, Novartis
Bo Fu, Sanofi
Mandy Jin, AbbVie
Jeffrey Joseph, Covance
Ray Lin, Genentech
Jingyi Liu, Eli Lilly
Yabing Mai, AbbVie
Inna Perevozskaya, GSK
Elena Polverejan, J&J
Satrajit Roychoudhury, Pfizer Inc.
Sammi Tang, Servier
Sabrina Wan, Merck & Co., Inc.
Casey Xu, BMS

Advisers

Ivan Chan, AbbVie
Jian-Xiong (George) Chu, CDRH
Christy Chuang-Stein, Chuang-Stein Consulting
Sylva Collins, CDER
Scott Evans, GWU
Shiowjen Lee, CBER
Kannan Natarajan, Pfizer Inc.
Jose Pinheiro, J&J
Renee Rees, CBER
Gary Rosner, JHU
Estelle Russek-Cohen, Consultant
Dong Wang, NCTR
Richard Zink, Lexitas

Key Dates

    Attend

  • June 15, 2021
    Conference Early Registration Opens
  • August 16, 2021
    Early Conference Registration Closes
  • August 30, 2021
    Housing Deadline
  • September 2, 2021
    Registration Cancellation Deadline
  • September 21, 2021 – September 23, 2021
    2020 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
  • Program Participants

  • April 16, 2021 – May 20, 2021
    Invited Abstract Submission Open for Accepted Parallel Sessions
  • May 25, 2021 – June 10, 2021
    Session Editing
  • July 7, 2021 – August 25, 2021
    Abstract Editing
  • July 16, 2021
    Speaker/Participant Registration Deadline
  • August 23, 2021
    Short Course materials due from Instructors